Blood :: New blood thinner studied for patients with leg and lung clots
A new oral blood thinner is being compared to an old standby to see if it works as well and is easier to manage long term, researchers say.
Pharmaceutical
Cancer :: $50 million for Auckland cancer research company
Proacta Therapeutics, a spin-out company of The University of Auckland, has raised US$35 million (NZ$51 million) in venture capital to continue its research into potential treatments for cancer.
Bird Flu :: Bird flu virus claims another woman
A 20 yrs. old Indonesian woman died from the avian influenza virus – H5N1 bird flu virus, in west Java on saturday night after undergoing a two-day treatment for bird flu symptoms.
Health Care :: No evidence of market manipulation in supply of pharmaceuticals – consumers do have choice
“Accusations of deliberately created shortages in the supply of cheaper, generic medicines in Australia reported today in the Daily Telegraph are unfounded,” Medicines Australia Chief Executive Ian Chalmers said today.
Prostate Cancer :: Gene elevating breast cancer risk also causes prostate cancer
An international multicenter research effort has identified a new genetic defect as a potential heritable breast cancer susceptibility candidate. The same PALB2 mutation also seems to in some measure cause prostate cancer.
Diabetes :: Chinese herb Ganoderma lucidum mushroom can cure diabetes
A team from the University of Western Sydney’s Centre for Complementary Medicine Research (CompleMED) is working with the Cardiac Health Institute to find out if the medicinal mushroom, Ganoderma lucidum, can reduce high blood sugar, often a precursor to diabetes – as well as treat other health problems.
HIV :: S. Africa HIV gel trials halted, 35 women HIV positive
HIV therapy halted in S. Africa, 35 women found HIV positive, health minister Manto ordered an enquiry, and a sequelae of reactions start.
Pain :: Opioid prescribing at forefront of pain medicine meeting
Opioid therapy, opioid prescribing and prescription drug diversion are provoking topics at the 23rd annual meeting of the American Academy of Pain Medicine (AAPM) at the Hilton New Orleans Riverside Hotel/Morial Convention Center, Feb. 7-10, 2007.
HIV :: New WHO Chief fails to stand up for people living with AIDS
AIDS Healthcare Foundation says WHO Chief’s lack of support for Thai action on compulsory AIDS drug licensing makes it clear that the health of people living with HIV in Thailand is not among her priorities.
Novartis :: HIV/AIDS advocates protest Novartis’ case challenge India Patent Law
Some HIV/AIDS advocacy groups are calling on pharmaceutical company Novartis to drop its legal challenge to the Indian government’s patent laws, saying that if the company wins the case it could restrict access to antiretroviral drugs for millions of people worldwide.